In bladder cancer, FOXD2-AS1 was found to be overexpressed in bladder cancer tissues, which further promoted bladder cancer progression and recurrence through forming a positive feedback loop with Akt and E2F1 (12). This evidence concerns the gene FOXD2 and urinary bladder cancer.